KM-2702

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameKM-2702
Drug Alias NamemIC-7IC-7KM-2702
ClassificationBiologics
Mechanisms of ActionIL-6 receptor agonistsCiliary neurotrophic factor receptor agonists
TargetsCiliary neurotrophic factor receptorIL-6 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBaker Idi Heart And Diabetes Institute Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity KielKinomedica Pty LtdBaker Idi Heart And Diabetes Institute Holdings Ltd
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A